首页 | 本学科首页   官方微博 | 高级检索  
     


Prions,prionoids and pathogenic proteins in Alzheimer disease
Authors:Karen H. Ashe  Adriano Aguzzi
Affiliation:1 Department of Neurology; N. Bud Grossman Center for Memory Research and Care; University of Minnesota; Minneapolis, MN USA;2Department of Neuroscience; N. Bud Grossman Center for Memory Research and Care; University of Minnesota; Minneapolis, MN USA;3GRECC; VA Medical Center; Minneapolis, MN USA;4Institute of Neuropathology; University Hospital Zurich; Zurich, Switzerland
Abstract:Like patients with prion disease, Alzheimer patients suffer from a fatal, progressive form of dementia. There is growing evidence that amyloid-β (Aβ) aggregates may be transmissible similar to prions, at least under extreme experimental conditions. However, unlike mice infected with prion protein (PrP) prions, those inoculated with Aβ do not die. The transmission of Aβ and PrP thus differs conspicuously in the neurological effects they induce in their hosts, the difference being no less than a matter of life and death. Far from being a mere academic nuance, this distinction between Aβ and PrP begs the crucial questions of what, exactly, controls prion toxicity and how prion toxicity relates to prion infectivity.
Keywords:Alzheimer’s disease  PrP  amyloid-β  pathogenic proteins  prionoids  prions  tau
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号